↓ Skip to main content

A Longitudinal Trial Comparing Chloroquine as Monotherapy or in Combination with Artesunate, Azithromycin or Atovaquone-Proguanil to Treat Malaria

Overview of attention for article published in PLOS ONE, August 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Citations

dimensions_citation
32 Dimensions

Readers on

mendeley
91 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A Longitudinal Trial Comparing Chloroquine as Monotherapy or in Combination with Artesunate, Azithromycin or Atovaquone-Proguanil to Treat Malaria
Published in
PLOS ONE, August 2012
DOI 10.1371/journal.pone.0042284
Pubmed ID
Authors

Miriam K. Laufer, Phillip C. Thesing, Fraction K. Dzinjalamala, Osward M. Nyirenda, Rhoda Masonga, Matthew B. Laurens, Abbie Stokes-Riner, Terrie E. Taylor, Christopher V. Plowe

Abstract

The predominance of chloroquine-susceptible falciparum malaria in Malawi more than a decade after chloroquine's withdrawal permits contemplation of re-introducing chloroquine for targeted uses. We aimed to compare the ability of different partner drugs to preserve chloroquine efficacy and prevent the re-emergence of resistance.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 91 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 3 3%
Unknown 88 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 17 19%
Student > Master 14 15%
Student > Ph. D. Student 9 10%
Student > Postgraduate 7 8%
Student > Doctoral Student 6 7%
Other 20 22%
Unknown 18 20%
Readers by discipline Count As %
Medicine and Dentistry 21 23%
Biochemistry, Genetics and Molecular Biology 11 12%
Agricultural and Biological Sciences 10 11%
Nursing and Health Professions 6 7%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Other 16 18%
Unknown 23 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 October 2012.
All research outputs
#2,196,438
of 22,675,759 outputs
Outputs from PLOS ONE
#28,017
of 193,562 outputs
Outputs of similar age
#14,776
of 169,174 outputs
Outputs of similar age from PLOS ONE
#485
of 4,218 outputs
Altmetric has tracked 22,675,759 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 193,562 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.0. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 169,174 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 4,218 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.